Assessment of arterial rigidity and daily profile of arterial pressure in women with newly detected breast cancer

Research objective: to evaluate arterial stiff ness indicators and its correlation with parameters of 24-hour ambulatory blood pressure monitoring (ABPM) in women with newly diagnosed breast cancer (BC).

Material and methods: a prospective cohort study in 158 women aged 27 to 64 years with a median age of 45.4 years and newly diagnosed BC at stage IIA–IIIB before chemotherapy was conducted. The first group included 109 patients with normal or high-normal office blood pressure (BP), and the second group included 49 women with previously diagnosed stage 1– 2 essential hypertension (EH) with low or moderate cardiovascular risk. All patients underwent indirect arteriography and ABPM.

 Results. According to ABPM data, “masked” arterial hypertension (MAH) was diagnosed in 54 (49.5%) women in the fi rst group. In patients with MAH, the mean daily level and diastolic BP time index exceeded the corresponding indicators in EH, and the magnitude of the morning rise in systolic BP was significantly lower. In 35.4% of the examined patients with EH, the pulse wave velocity (PWV) was increased, and in 17.4% it was pathological. With MAH, these changes were recorded in 28.5% and 14.1% of cases, respectively. The odds ratio showed that in women with normal BP, the probability of an increase in PWV >10 m/s increased by 1.6 times, and in the presence of comorbidity with MAH and EH, it increased by 2.2 and 2.4 times, respectively. The risk of an increase in central systolic BP >125 mm Hg and pulse BP >60 mm Hg was highest in patients with EH.

Conclusion: Among young and middle-aged women with newly diagnosed BC, a significant number of cases of MAH and EH are detected, which determines the need to evaluate arterial stiff ness and daily BP profiles before starting antitumor therapy.

1. Mensah G.A., Roth G.A., Fuster V. The global burden of cardiovascular diseases and risk factors: 2020 and beyond. J. Am. Coll. Cardiol. 2019;74(20):2529–2532. DOI: 10.1016/j.jacc.2019.10.009

2. Erina A.M., Rotar O.P., Solntsev V.N., Shalnova S.A., Deev A.D., Baranova E.I. et al. Epidemiology of arterial hypertension in Russian Federation — importance of choice of criteria of diagnosis. Kardiologiia. 2019;59(6):5–11. (In Russian). DOI: 10.18087/cardio.2019.6.2595

3. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021;71(3):209–249. DOI: 10.3322/caac.21660

4. Brodskaya T.A., Geltser B.I., Satalkina T.S., Knysh S.V., Shekunova O.I. Hypertension and breast cancer in women: mechanisms of comorbidity and drug iatrogenism. Arterial’naya Gipertenziya. 2022;28(2):147–156. (In Russian). DOI: 10.18705/1607-419X-2022-28-2-147-156

5. Mehta L.S., Watson K.E., Barac A., Beckie T.M., Bittner V., Cruz-Flores S. et al. American heart association cardiovascular disease in women and special populations committee of the council on clinical cardiology; council on cardiovascular and stroke nursing; and council on quality of care and outcomes research. cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the american heart association. Circulation. 2018;137(8):e30–e66. DOI: 10.1161/CIR.0000000000000556

6. Vasyuk Yu.A., Gendlin G.E., Emelina E.I., Shupenina E.Yu., Balluzek M.F., Barinova I.V. et al. Consensus statement of Russian experts on the prevention, diagnosis and treatment of cardiotoxicity in anticancer therapy. Rossijskij kardiologicheskij zhurnal. 2021;26(9):152–233. (In Russian). DOI: 10.15829/1560-4071-2021-4703

7. Geltser B.I., Shakhgeldyan K.I., Kotelnikov V.N., Vetrova O.O., Orlova-Ilyinskaya V.V., Karpov R.S. Phenotyping of “masked” arterial hypertension according to the results of clustering data of 24-hour arterial pressure monitoring. Rossijskij kardiologicheskij zhurnal. 2020;25(3):57–62. (In Russian). DOI: 10.15829/1560-4071-2020-3-3286

8. Chirinos J.A., Segers P., Hughes T., Townsend R. Large-artery stiffness in health and disease: JACC state-of-the-art review. J. Am. Coll. Cardiol. 2019;74(9):1237–1263. DOI: 10.1016/j.jacc.2019.07.012

9. Parr S.K., Steele C.C., Hammond S.T., Turpin V.R.G., Ade C.J. Arterial stiffness is associated with cardiovascular and cancer mortality in cancer patients: Insight from NHANESIII. J. Cardiol. Hypertens. 2021;9:100085. DOI: 10.1016/j.ijchy.2021.100085

10. Satalkina T.S., Brodskaya T.A., Geltser B.I. Arterial hypertension and anticancer drug therapy: pathophysiological relationships and clinical significance. Pacific Medical Journal. 2022;4:5–10. (In Russian). DOI: 10.34215/1609-1175-2022-4-5-10

11. Ostroumova O.D., Borisova E.V., Ostroumova T.M., Kochetkov A.I. Day-to-day blood pressure variability: prognostic value, assessment methods, and impact of antihypertensive therapy. Kardiologiya. 2017;57(12):62–72. (In Russian). DOI: 10.18087/cardio.2017.12.10068

12. Kozłowska K., Kozłowski L., Małyszko J. Hypertension prevalence in early breast cancer patients undergoing primary surgery. Adv. Med. Sci. 2019;64(1):32–36. DOI: 10.1016/j.advms.2018.10.003

13. Zhu Y., Liu X., Ding X., Wang F., Geng X. Telomere and its role in the aging pathways: telomere shortening, cell senescence and mitochondria dysfunction. Biogerontology. 2019;20(1):1–16. DOI: 10.1007/s10522-018-9769-1

14. Cloonan S.M., Kim K., Esteves P., Trian T., Barnes P.J. Mitochondrial dysfunction in lung ageing and disease. Eur. Respir. Rev. 2020;29:200165. DOI: 10.1183/16000617.0165-2020

15. Prousi G.S., Joshi A.M., Atti V., Addison D., Brown S.A., Guha A., Patel B. Vascular inflammation, cancer, and cardiovascular diseases. Curr. Oncol. Rep. 2023. DOI: 10.1007/s11912-023-01426-0

16. Jiang Y., Xing A., Hidru T.H. et al. The association between arterial stiffness and cancer occurrence: Data from Kailuan cohort study. Front Cardiovasc. Med. 2023;10:1112047. Published 2023 Mar 1. DOI: 10.3389/fcvm.2023.1112047

17. Humphrey J.D., Harrison D.G., Figueroa C.A., Lacolley P., Laurent S. Central artery stiffness in hypertension and aging: a problem with cause and consequence. Circ. Res. 2016;118(3):379–381. DOI: 10.1161/CIRCRESAHA.115.307722

18. Bulas J., Potocarova M., Kupcova V., Gaspar L., Wimmer G., Murin J. Central systolic blood pressure increases with aortic stiffness. Bratisl. Lek. Listy. 2019;120(12):894–898. DOI: 10.4149/BLL_2019_150

19. Omboni S., Posokhov I., Parati G., Arystan A., Tan I., Barkan V. et al. Variable association of 24-h peripheral and central hemodynamics and stiffness with hypertension-mediated organ damage: the VASOTENS Registry. J. Hypertens. 2020;38(4):701–15. DOI: 10.1097/HJH.0000000000002312

20. Souza C.A., Simões R., Borges K.B.G., Oliveira A.N., Zogeib J.B., Alves B. et al. Arterial stiffness use for early monitoring of cardiovascular adverse events due to anthracycline chemotherapy in breast cancer patients. a pilot study. Arq. Bras. Cardiol. 2018;111(5):721–728. DOI: 10.5935/abc.20180168